<!DOCTYPE html>
<html lang="en-US"><head>
		<meta charset="UTF-8">
		<title>FR940627-0-00239</title>
	</head>
	<body>
		<main>
			<p><!-- PJG STAG 4700 -->  <!-- PJG ITAG l=11 g=1 f=1 --> (8)  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> Safety procedures and requirements.  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> In the case of  <!-- PJG 0012 frnewline --> potentially explosive test substance concentrations, care shall  <!-- PJG 0012 frnewline --> be taken to avoid generating explosive atmospheres.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> (i) It is mandatory that the upper explosive limit (UEL)  <!-- PJG 0012 frnewline --> and lower explosive limit (LEL) for the fuel and/or fuel  <!-- PJG 0012 frnewline --> additive(s) that are being tested be determined. These limits  <!-- PJG 0012 frnewline --> can be found in the material safety data sheets (MSDS) for each  <!-- PJG 0012 frnewline --> substance and in various reference texts. The air concentration  <!-- PJG 0012 frnewline --> of the fuel or additive-base fuel mixture in the generation  <!-- PJG 0012 frnewline --> system, dilution/delivery system, and the exposure chamber system  <!-- PJG 0012 frnewline --> shall be calculated to ensure that explosive limits are not  <!-- PJG 0012 frnewline --> present.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> (ii) Storage, handling, and use of fuels or fuel/additive  <!-- PJG 0012 frnewline --> mixtures shall follow guidelines given in 29 CFR 1910.106.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> (iii) Monitoring for carbon monoxide (CO) levels is  <!-- PJG 0012 frnewline --> mandatory for combustion systems. CO shall be continuously  <!-- PJG 0012 frnewline --> monitored in the immediate area of the engine/vehicle system and  <!-- PJG 0012 frnewline --> in the exposure chamber(s).  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> (iv) Air samples shall be taken quarterly in the immediate  <!-- PJG 0012 frnewline --> area of the vapor generation system and the exposure chamber  <!-- PJG 0012 frnewline --> system, or once at the beginning, middle, and end of the study  <!-- PJG 0012 frnewline --> for shorter studies. These samples shall be analyzed by methods  <!-- PJG 0012 frnewline --> described in paragraph (d)(6)(ii)(B) of this section.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> (v) With the presence of fuels and/or fuel additives, all  <!-- PJG 0012 frnewline --> electrical and electronic equipment must be grounded. Also, the  <!-- PJG 0012 frnewline --> dilution/delivery system and chamber exposure system must be  <!-- PJG 0012 frnewline --> grounded. Guidelines for grounding are given in 29 CFR 1910.304.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> (9)  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> Quality control and quality assurance procedures <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> _(i)  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> Standard operating procedures (SOPs). <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  SOPs for  <!-- PJG 0012 frnewline --> exposure operations, sampling instruments, animal handling, and  <!-- PJG 0012 frnewline --> analytical methods shall be written during the developmental  <!-- PJG 0012 frnewline --> phase of the study.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> (ii) Technicians/operators shall be trained in exposure  <!-- PJG 0012 frnewline --> operation, maintenance, and documentation, as appropriate, and  <!-- PJG 0012 frnewline --> their training shall be documented.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> (iii) Flow meters, sampling instruments, and balances used  <!-- PJG 0012 frnewline --> in the inhalation experiments shall be calibrated with standards  <!-- PJG 0012 frnewline --> during the developmental phase to determine their sensitivity,  <!-- PJG 0012 frnewline --> detection limits, and linearity. During the exposure period,  <!-- PJG 0012 frnewline --> instruments shall be checked for calibration and documented to  <!-- PJG 0012 frnewline --> ensure that each instrument still functions properly.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> (iv) The mean exposure concentration shall be within 10  <!-- PJG 0012 frnewline --> percent of the target concentration on 90 percent or more of  <!-- PJG 0012 frnewline --> exposure days. The coefficient of variation shall be within 25  <!-- PJG 0012 frnewline --> percent of target on 90 percent or more of exposure days. For  <!-- PJG 0012 frnewline --> example, a manufacturer might determine a mean exposure  <!-- PJG 0012 frnewline --> concentration of its product's exposure emissions by identifying  <!-- PJG 0012 frnewline --> ``marker'' compound(s) typical of the emissions of the fuel or  <!-- PJG 0012 frnewline --> fuel/additive mixture under study as a surrogate for the total of  <!-- PJG 0012 frnewline --> individual compounds in those exposure emissions. The  <!-- PJG 0012 frnewline --> manufacturer would note any concentration changes in the level of  <!-- PJG 0012 frnewline --> the ``marker'' compound(s) in the sample's daily emissions for  <!-- PJG 0012 frnewline --> biological testing.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> (v) The spatial variation of the chamber concentration  <!-- PJG 0012 frnewline --> shall be 10 percent, or less. If a higher spatial variation is  <!-- PJG 0012 frnewline --> observed during the developmental phase, then air mixing in the  <!-- PJG 0012 frnewline --> chamber shall be increased. In any case, animals shall be rotated  <!-- PJG 0012 frnewline --> among the various cages in the exposure chamber(s) to insure each  <!-- PJG 0012 frnewline --> animal's uniform exposure during the study.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> (e)  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> Data and reporting.  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> Data shall be summarized in  <!-- PJG 0012 frnewline --> tabular form, showing for each group the number of animals at the  <!-- PJG 0012 frnewline --> start of the test, the number of animals showing lesions, the  <!-- PJG 0012 frnewline --> types of lesions, and the percentage of animals displaying each  <!-- PJG 0012 frnewline --> type of lesion.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> (1)  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> Treatment of results.  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> All observed results,  <!-- PJG 0012 frnewline --> quantitative and incidental, shall be evaluated by an appropriate  <!-- PJG 0012 frnewline --> statistical method. Any generally accepted statistical method  <!-- PJG 0012 frnewline --> may be used; the statistical methods shall be selected during the  <!-- PJG 0012 frnewline --> design of the study.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG /STAG --></p>
		</main>
</body></html>
            